About Hylasco Biotechnology
Hylasco Biotechnology is an Agriculture company founded in 2012. Breeds and supplies rodents for scientific research and animal health monitoring. It operates on a B2B model. Its Indian entity Hylasco Bio-Technology (India) Private Limited reported revenue of ₹28.41 Cr. Hylasco Biotechnology offers products and services including Research Animal Models, Equipment and Consumables, and Health Monitoring. Its focus areas include Biotechnology, Animal Research, Breeding and Supply and Rodents.
Company details
Hylascobio is a biotechnology company that focuses on breeding and supplying research animal models, such as rats and mice, under license from Charles River. They employ proven methodologies for commercial supply and offer services like health monitoring and equipment provision. Based in Telangana, India, they serve scientific institutions with a total quality management approach to ensure reliable animal models for various research needs.
- SectorsAgriculture
- Email••••••••
- Website hylascobio.in
- Legal Name Hylasco Bio-Technology (India) Private Limited
- Date of Incorporation 03 May, 2012
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹28.41 Cr
FY 2025 · -2% YoY
- Indian entity net profit₹2.31 Cr
FY 2025 · 8% margin
- Indian entity EBITDA₹5.77 Cr
FY 2025 · 20% margin
Associated legal entities of Hylasco Biotechnology
Hylasco Biotechnology operates through Hylasco Bio-Technology (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hylasco Bio-Technology (India) Private Limited CIN U01409TG2012PTC080696 | Active | 03 May 2012 | Hyderabad, Telangana | ₹28.4 Cr | 94 | 6 | View details |
Products & Services of Hylasco Biotechnology
Hylasco Biotechnology offers a comprehensive portfolio of products and services, including Research Animal Models, Equipment and Consumables, and Health Monitoring.
Breeds rats and mice for scientific research applications.
Provides tools and materials for animal research needs.
Offers monitoring for research animal health and welfare.
Board of directors of Hylasco Bio-Technology (India) Private Limited (Hylasco Biotechnology)
Hylasco Bio-Technology (India) Private Limited is the primary company behind Hylasco Biotechnology. The board of Hylasco Bio-Technology (India) Private Limited currently have 4 directors; the longest-serving is Richard Charn Sun Lee, appointed in 2012. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Richard Charn Sun Lee DIN 05264525 | Director | 03 May 2012 | 14 yrs 5 mo | Hylasco Bio-Technology (India) Private Limited |
| Jae Jin Chang DIN 07760518 | Director | 23 Feb 2017 | 9 yrs 8 mo | Hylasco Bio-Technology (India) Private Limited |
| Cheng Chen Chung DIN 08012458 | Nominee Director | 21 Sep 2017 | 9 yrs 1 mo | Hylasco Bio-Technology (India) Private Limited |
| Khaleel Ahmed Mohammad DIN 10548409 | Managing Director | 14 Mar 2024 | 2 yrs 7 mo | Hylasco Bio-Technology (India) Private Limited |
Financials of Hylasco Biotechnology
Figures of Hylasco Bio-Technology (India) Private Limited, the primary company behind Hylasco Biotechnology, for FY 2025. Revenue was ₹28.41 Cr (-2% year on year). Net profit was ₹2.31 Cr (8% margin). EBITDA was ₹5.77 Cr (20% margin). Revenue has grown at a compounded annual rate of +14% over three years and +22% over five years.
- ₹28.41 CrRevenue · FY 2025 · -2% YoY
- ₹2.31 CrNet profit · 8% margin
- ₹5.77 CrEBITDA · 20% margin
- ₹27.31 CrPaid-up capital
- 94Employees (provident fund records)
- +14%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Hylasco Bio-Technology (India) Private Limited are on its company page.
Detailed financial statements for Hylasco Biotechnology
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hylasco Biotechnology
Hylasco Biotechnology was founded in 2012.
The primary company behind Hylasco Biotechnology, Hylasco Bio-Technology (India) Private Limited, reported revenue of ₹28.41 Cr for FY 2025, down 2% year on year.
Hylascobio is a biotechnology company that focuses on breeding and supplying research animal models, such as rats and mice, under license from Charles River. They employ proven methodologies for commercial supply and offer services like health monitoring and equipment provision. Based in Telangana, India, they serve scientific institutions with a total quality management approach to ensure reliable animal models for various research needs.
Hylasco Biotechnology offers Research Animal Models, Equipment and Consumables, and Health Monitoring.
Hylasco Biotechnology operates through Hylasco Bio-Technology (India) Private Limited.
The legal entities of Hylasco Biotechnology currently have 6 directors, including Jae Jin Chang, Richard Charn Sun Lee, Ravina Sood and others.